Research Studies and Clinical Trials Search
Results
Cystic Fibrosis-Related Diabetes: A Study Comparing the Safety of the Bionic Pancreas Device Relative to Usual Care.
This study is being done to learn how well the iLet Bionic Pancreas system works in patients with Cystic Fibrosis-Related Diabetes (CFRD). - 14 years old or older - Have Cystic Fibrosis Related Diabetes...
This study is being done to learn how well the iLet Bionic Pancreas system works in patients with Cystic Fibrosis-Related Diabetes (CFRD). - 14 years old or older - Have Cystic Fibrosis Related Diabetes - Be on treatment of insulin for at least 3 months
Diabetes Type I: A study of medication, CNP-103, to prevent islet cell destruction.
This study is being done for adolescents/young adults/adults: * 12-35 years old. * Newly diagnosed Type I Diabetes...
This study is being done for adolescents/young adults/adults: * 12-35 years old. * Newly diagnosed Type I Diabetes. This study is looking to see if the medication, CNP-103, can help the body preserve its ability to produce insulin by reducing the attack on the insulin-producing beta cells in the pancreas.
Type I Diabetes: A study to better understand those at risk for developing Type I Diabetes
The overall objective of this study is to perform baseline and repeat assessments over time of the metabolic and immunologic status of individuals at risk for type 1 diabetes (T1D) to: (a) characterize their risk for developing T1D and identify subjects eligible for prevention...
The overall objective of this study is to perform baseline and repeat assessments over time of the metabolic and immunologic status of individuals at risk for type 1 diabetes (T1D) to: (a) characterize their risk for developing T1D and identify subjects eligible for prevention trials, (b) describe the pathogenic evolution of T1D, and (c) increase the understanding of the pathogenic factors involved in the development of T1D.
Youth with Insulin Treated Diabetes: A study to collect feedback on a diabetes phone app
This study is for: - Participants include Parent(s)/Guardians of children age 1-18 who have insulin treated diabetes or youth age 13-22 who have insulin treated diabetes The goal of this study is to test if a diabetes phone app has an impact on engagement and understanding of...
This study is for: - Participants include Parent(s)/Guardians of children age 1-18 who have insulin treated diabetes or youth age 13-22 who have insulin treated diabetes The goal of this study is to test if a diabetes phone app has an impact on engagement and understanding of diabetes care.